PRESS RELEASE published on 06/16/2023 at 08:00, 2 years 7 months ago Travis Perkins plc - trading update
PRESS RELEASE published on 06/14/2023 at 16:26, 2 years 7 months ago Travis Perkins: TR1 Notification of Major Share Interest
PRESS RELEASE published on 06/09/2023 at 17:51, 2 years 7 months ago Travis Perkins: Director/PDMR Shareholding
PRESS RELEASE published on 05/23/2023 at 11:24, 2 years 8 months ago Travis Perkins: Director Declaration
PRESS RELEASE published on 05/19/2023 at 18:08, 2 years 8 months ago Travis Perkins: Director/PDMR Shareholding
PRESS RELEASE published on 05/18/2023 at 12:45, 2 years 8 months ago Travis Perkins: Non-executive Director (elect - not a PDMR) Shareholding
PRESS RELEASE published on 05/11/2023 at 16:46, 2 years 8 months ago Travis Perkins: Director/PDMR Shareholding
PRESS RELEASE published on 04/27/2023 at 08:00, 2 years 9 months ago Travis Perkins: Directorate Change
PRESS RELEASE published on 04/25/2023 at 08:00, 2 years 9 months ago Travis Perkins plc - first quarter trading update for the three months to 31 March 2023
Published on 01/30/2026 at 14:00, 2 hours 15 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 7 hours 40 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 8 hours 15 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 14 hours ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 16 hours 15 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 16:00, 15 minutes ago Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation
Published on 01/30/2026 at 15:57, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 18:00, 22 hours 15 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 22 hours 30 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 22 hours 30 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025